IL6 and breast cancer: Furthermore, a range of paracrine signaling factors and altered gene expressions explain how CAAs alter the metabolic phenotype of breast cancer cells, including overexpressing proteases and elevating adipokines, including interleukin 6 (IL-6) (108).